MedTrace Logo

The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease

NCT04277767 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-04-01

No results posted yet for this study

Summary

Alzheimer's disease (AD) is a prevalent, long-term progressive degenerative disorder with great social impact. It is currently thought that, in addition to neurodegeneration, vascular changes also play a role in the pathophysiology of the disease. Meantime, EEG resting state has also demonstrated significant change in patients with AD in neuroscience research area. Thus, the combination of these sensitive biomarkers would lead to a potential new biomarker for detection of AD, which has higher specificity and sensitivity.

Conditions

Interventions

DIAGNOSTIC_TEST

observational

No intervention

Sponsors & Collaborators

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Jin Yuan, phD · Zhongshan Ophthalmological Center, Sun Yat-sen University

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-02-01
Completion
2023-07-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04277767 on ClinicalTrials.gov